This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Petryshen, T., Middleton, F., Kirby, A. et al. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry 10, 328 (2005). https://doi.org/10.1038/sj.mp.4001661
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001661
This article is cited by
-
Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult mice
Scientific Reports (2018)
-
mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia
Psychopharmacology (2016)
-
No Association Between NRG1 and ErbB4 Genes and Psychopathological Symptoms of Schizophrenia
NeuroMolecular Medicine (2014)
-
Neuregulin-1 signalling and antipsychotic treatment
Psychopharmacology (2013)
-
Variations in the Vesicular Monoamine Transporter 1 Gene (VMAT1/SLC18A1) are Associated with Bipolar I Disorder
Neuropsychopharmacology (2006)